Key Takeaways
- • NeuroXess, a Chinese brain-computer interface startup, raised around $105M in Series B funding led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital, according to Axios.
- • Intake Breathing, a Santa Barbara, Calif., maker of a magnetic nasal dilator, raised $62M from Camino Partners.
- • The Axios newsletter headline also references Bon Secours' acquisition of Surgery Partners and a General Catalyst leadership shakeup, but the available source text does not provide details on either.
Summary
Axios reported that NeuroXess, a Chinese brain-computer interface startup, raised around $105M in Series B funding. The round was led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital. The figure is reported as approximate.
In the same venture capital roundup, Intake Breathing, a Santa Barbara, California-based maker of a magnetic nasal dilator, raised $62M from Camino Partners.
The newsletter's headline also flags Bon Secours' acquisition of Surgery Partners and a shakeup at General Catalyst. The available source material does not include details on either development, so they are not covered in this summary.
In the same venture capital roundup, Intake Breathing, a Santa Barbara, California-based maker of a magnetic nasal dilator, raised $62M from Camino Partners.
The newsletter's headline also flags Bon Secours' acquisition of Surgery Partners and a shakeup at General Catalyst. The available source material does not include details on either development, so they are not covered in this summary.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.